verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: nivagen pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler nivagen pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

verapamil hydrochloride 180 mg/1

Manufacturer
Nivagen Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 75834-158
Product ID 75834-158_ebbb0dad-ab4d-4d6c-aebb-d65e2dd08c28
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206173
Listing Expiration 2026-12-31
Marketing Start 2019-05-15

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 75834158
Hyphenated Format 75834-158

Supplemental Identifiers

RxCUI
897640 897649 897659
UPC
0375834320052 0375834320014
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA206173 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (75834-158-01)
  • 500 TABLET in 1 BOTTLE (75834-158-05)
source: ndc

Packages (2)

75834-158-01 100 TABLET in 1 BOTTLE (75834-158-01) 75834-158-05 500 TABLET in 1 BOTTLE (75834-158-05)

Ingredients (1)

verapamil hydrochloride (180 mg/1)

Linked Drug Pages (1)

VERAPAMIL HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ebbb0dad-ab4d-4d6c-aebb-d65e2dd08c28", "openfda": {"upc": ["0375834320052", "0375834320014"], "unii": ["V3888OEY5R"], "rxcui": ["897640", "897649", "897659"], "spl_set_id": ["e36e485f-fbed-4e30-9a63-984931f2e54e"], "manufacturer_name": ["Nivagen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (75834-158-01)", "package_ndc": "75834-158-01", "marketing_start_date": "20190515"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (75834-158-05)", "package_ndc": "75834-158-05", "marketing_start_date": "20190515"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "75834-158_ebbb0dad-ab4d-4d6c-aebb-d65e2dd08c28", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "75834-158", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "Nivagen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "ANDA206173", "marketing_category": "ANDA", "marketing_start_date": "20190515", "listing_expiration_date": "20261231"}